Jinhyuk Bhin

9PUBLICATIONS
70CO-AUTHORS
Metabolic medicineCancer geneticsMolecular targetsCancer cell biologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 31, 2026
PDE3B as a multi-organ therapeutic node in the gut-liver axis of metabolic dysfunction-associated steatohepatitis.

|Jul 13, 2026
Translating whole-genome doubling into precision medicine in cancer.

|Dec 29, 2025
C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3.

Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg

|Jun 24, 2025
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.

Daniel Zingg, Chi-Chuan Lin, Julia Yemelyanenko

|Apr 30, 2025
Large-scale Characterization of Orthotopic Cell Line-Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness.

Catrin Lutz, Xue Chao, Bim de Klein

|Aug 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.

Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao

Pageof 2

Frequent Collaborators

7 joint publications

Jos Jonkers

6 joint publications

Lodewyk Wessels

5 joint publications

Daniel Zingg

5 joint publications

Julia Yemelyanenko